| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-21 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-13 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |